4th Quarter - Report

HOSPIRA, INC. for HOSPIRA INC

Period 4th Quarter 2011 Filed Jan 20, 2012 Signed by Juliana M. Reed; Vice President, Government Affairs

Official filing
Firm
HOSPIRA, INC.
Client
HOSPIRA INC
Income
—
Expenses
$160,000
Expense method
A: Lobbying Disclosure Act definitions

What was lobbied

2 issue areas, each in the filer's own words, with who lobbied on it and where.

Taxation/Internal Revenue Code TAX

H.R.942 American Research and Competitiveness Act of 2011

LobbyistCovered position, as disclosed
LORI NEAL BOWMAN —
JULIANA REED —

Contacted: Health & Human Services, Dept of (HHS); SENATE; HOUSE OF REPRESENTATIVES

Bills named: H.R. 942 (112th)

Health Issues HCR

Antimicrobial Resistance and Healthcare Acquired Infections; Drug Shortages; Safe Injection Practices; H.R.2245 / S.296 Preserving Access to Life-Saving Medications Act; S.3690 Drug Safety and Accountability Act; S.454 Strengthening Program Integrity and Accountability in Health Care Act of 2011; 340B drug discount program; User Fees; Biosimilars

LobbyistCovered position, as disclosed
LORI NEAL BOWMAN —
JULIANA REED —

Contacted: Health & Human Services, Dept of (HHS); HOUSE OF REPRESENTATIVES; SENATE

Bills named: S. 3690 (112th), S. 454 (112th), H.R. 2245 (112th), S. 296 (112th)

Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.